Together with some outstanding partners from academy (FORTH Institute of Molecular Biology & Biotechnmology (IMBB-FORTH), the University of Thessaly (UTH), the University of Cyprus (UCY), and the King´s College London (KCL), Gremse-IT GmbH forms the consortium of the SoftReach Project. The aim of this innovative project is to revolutionize neurological disorder treatment with robotics.

About the project: "The treatment of neurological disorders (ND) through the use of robotics and imaging can improve the efficacy and safety of treatments. The SoftReach EU funded project aims to revolutionize the clinical practice of ND treatments by developing image-guided minimally invasive robotic technology for localized delivery of therapeutics to deep-brain regions involved in ND pathology. To this end, SoftReach will develop a flexible robotic endoscope, equipped with a μl-sized tissue construct payload, that will be guided through the spine up to the brain-ventricles. There, the robot will perform precise control over the delivery of therapeutics on the brain ventricles tissue, enabling the implementation of promising cell and gene therapies, targeting the adult hippocampal neurogenesis as a novel pharmacological approach. "

This project is funded and supported by the European Innovation Council.

‍